LIFE Atyr Pharma Inc

aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology.

$2.24  -0.03 (-1.32%)
As of 02/02/2023 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/07/2015
Outstanding shares:  28,625,046
Average volume:  139,738
Market cap:   $64,978,854
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   -3.38
PB ratio:   0.64
PS ratio:   0.00
Return on equity:   -39.34%
Net income %:   -1,384,272.07%